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Objective The objective was to determine if participantsÕ strengthof-preference scores for elective health care interventions at the endof-life (EOL) elicited using a non-engaging technique are aﬀected by
their prior use of an engaging elicitation technique.

Design Medicare beneﬁciaries were randomly selected from a larger
survey sample. During a standardized interview, participants considered four scenarios involving a choice between a relatively less- or
more-intense EOL intervention. For each scenario, participants
Accepted for publication
indicated their favoured intervention, then used a 7-point Leaning
15 July 2010
Scale (LS1) to indicate how strongly they preferred their favoured
Keywords: in-person interview, Medicare population, preference elicitation intervention relative to the alternative. Next, participants engaged in
a Threshold Technique (TT), which, depending on the participantÕs
methods, preference sensitive care,
public engagement, strength-of-prefer- initially favoured intervention, systematically altered a particular
ences
attribute of the scenario until the participant switched preferences.
Finally, they repeated the LS (LS2) to indicate how strongly they
preferred their initially-favoured intervention.
Results Two hundred and two participants were interviewed (189–
198 were included in this study). The concordance of individual
participantsÕ LS1 and LS2 scores was assessed using Kendall tau-b
correlation coeﬃcients; scores of 0.74, 0.84, 0.85 and 0.89 for
scenarios 1–4, respectively, were observed.
Conclusion Kendall tau-b statistics indicate a high concordance
between LS scores, implying that the interposing engaging TT
exercise had no signiﬁcant eﬀects on the LS2 strength-of-preference
scores. Future investigators attempting to characterize the distributions of strength-of-preference scores for EOL care from a large,
diverse community could use non-engaging elicitation methods. The
potential limitations of this study require that further investigation
be conducted into this methodological issue.
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Background
When a society is attempting to provide publicly-funded health services, it inevitably faces
the need to prioritize its scarce health care
resources.1 According to the principles of medical ethics, one could argue that eﬀorts to
address this need should be carried out in an
explicit manner, actively seeking the involvement of a societyÕs members in decisions about
priority-setting and resource allocation.2,3 This
argument may be even more relevant in the area
of preference-sensitive care, in which there is
insuﬃcient clinical evidence to support one
optional intervention over all others, or in which
there is no clear consensus that a particular
interventionÕs potential beneﬁts overwhelmingly
outweigh its potential harms.4
To foster the involvement of its members in
prioritization eﬀorts, a society would need to
collect empirical data about the publicÕs attitudes
towards diﬀerent preference-sensitive health care
options. Moreover, that society would need to
collect these data in a manner that allows the
identiﬁcation of population sub-groups who,
even though they favour the same option, may
diﬀer in terms of the strength-of-preference
scores they would ascribe to that option.5
From a policy perspective, this may be important in order to avoid prioritizing resources and
instituting policies that are inadvertently mismatched with the preference-sensitive services that
diﬀerent sub-groups in the public actually want.4
From an ethical perspective, it may be particularly
important to avoid mismatches between what
diﬀerent sub-groups in the public strongly ÔwantÕ
and what those sub-groups actually ÔgetÕ in the
context of preference-sensitive care.3
A measurement challenge
These arguments, in turn, imply that we need to
be able to collect strength-of-preference scores
for health care options from the public. However, several measurement challenges are inherent in eﬀorts to discriminate between relatively
strongly- and weakly-held preferences for health
care options. The particular challenge addressed

by this paper is whether the designers of future
community-wide surveys could, with a fair
degree of conﬁdence, use a relatively ÔnonengagingÕ elicitation technique to collect overall
strength-of-preference scores for the particular
health care options under consideration.
A relatively non-engaging elicitation technique involves: outlining a particular clinical
context to the respondent; presenting her with
two (or more) therapeutic options for dealing
with that situation; asking her to indicate which
is her overall favoured option; and then asking
her to provide an overall strength-of-preference
score for that particular option on some kind of
response scale.6 In large-scale studies involving
multiple interviewers who are eliciting strengthof-preference reports from community-dwelling
respondents, non-engaging elicitation techniques
would be quicker, easier, and less costly to
employ than ÔengagingÕ elicitation techniques
(which are described below).
However, non-engaging elicitation techniques
do not actively involve respondents in making
explicit tradeoﬀs among the diﬀerent positive
and negative attributes that are associated with
the alternative health care options.7 Without
such involvement, a respondent may tend to
respond to the choice problem without investing
much eﬀort in genuinely considering what would
be personally at stake in choosing one health
care option over another, if she were actually
facing this situation in real time. Accordingly,
the strength-of-preference scores obtained using
a relatively non-engaging elicitation technique
may capture a somewhat superﬁcial or unstable
picture that is only partially reﬂective of a participantÕs actual strength of preference for a
particular favoured health care option.
On the other hand, a relatively more engaging
elicitation technique does actively involve
respondents in making these explicit tradeoﬀs
among the health care optionsÕ positive and negative attributes. One could argue that this active
involvement heightens the salience of the preference elicitation task, encourages the respondent
to invest the eﬀort required to deliberate about the
acceptability or unacceptability of the health
care optionsÕ attributes, and thereby leads the
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respondent to gain clearer individualized insight
into her own preference structure.8 Accordingly,
the strength-of-preference scores obtained using
an engaging elicitation technique may tap into a
respondentÕs strength of preference for a particular favoured option in a deeper, more stable way.
If so, then we would wish to use more engaging
elicitation techniques – such as the Analytic
Hierarchy Process9,10 or the Threshold Technique
(TT) 11,12– when we try to identify sub-groups of
community-dwelling individuals who diﬀer
according to the strength-of-preference scores
they ascribe to particular health care options.
However, these engaging techniques would be
slower, more complex, and costlier to employ in
population survey study designs than would the
non-engaging techniques described above.
A strategy
One way to explore this issue is to see what
happens when, after considering a particular
clinical decision situation, a respondent is: (i) ﬁrst
asked to indicate her strength-of-preference score
for a favoured option on a non-engaging Leaning
Scale (LS) (a form of category rating scale); then
(ii) is asked to interact with an engaging TT
(which leads the respondent to consider that
favoured option in greater detail, by systematically and repeatedly altering a key attribute of
one or the other option and, with each alteration,
asking the respondent if she would continue with
the favoured option); and ﬁnally (iii) is asked
again to indicate her non-engaged LS strengthof-preference score for that initially-favoured
option.
If the intervening engaging technique actually
provides the respondent with deeper insights
into her own preferential attitudes towards the
options, then we would expect that the strengthof-preference score she reports on the second
non-engaging occasion may diﬀer from the
strength-of-preference score she reported on the
ﬁrst non-engaging occasion. Such shifts, if they
occur, could imply that slower, more complex,
and costlier engaging techniques would need to
be used in future, large-scale, community-wide
surveys assessing the distributions of public

preferential attitudes towards elective therapeutic options.
Study purpose
We had an opportunity to carry out this
exploratory work, as a follow-up investigation
(see the Methods section, below) involving some
of the participants in a large, nationally-representative telephone survey of approximately
4000 Medicare beneﬁciaries in the US.13–16
For several reasons, we elected to use an endof-life decision-making context. During end-oflife care, patients are often provided with interventions that are, at the core, optional in nature
and involve diﬃcult tradeoﬀs between the length
and quality of life; their attitudes towards those
interventions – and the factors inﬂuencing those
attitudes – can vary widely.17–21 Furthermore,
the contemplation of these issues is neither a
wholly foreign nor a trivial task. There is some
evidence that the anticipatory contemplation of
preferences about end-of-life care generates reasonable responses from Medicare beneﬁciaries18;
therefore, a non-engaging preference elicitation
task should at least be feasible for the participants. Also, decisions at the end-of-life are usually one-time events, and it is unlikely that the
participants will have repeatedly faced these
decisions in the past. If engaging techniques
involving trade-oﬀs actually generate greater
degrees of salience, encourage participants to
gain deeper insights into their own preference
structure, and induce an eﬀect on their responses
to a subsequent non-engaging approach, we
postulated that the end-of-life context would
allow that eﬀect to emerge more readily than if
we used a clinical context in which the participant
encountered more frequently, or in which the
consequences were perceived as being less severe
(e.g. visiting a physicianÕs oﬃce for the ﬂu).
Therefore, the overall purpose of the followup study reported here was to address the following methodological research question: When
community-dwelling Medicare beneﬁciaries are
asked to consider a hypothetical end-of-life
situation with a limited anticipated survival
time, to consider two optional actions – one of

 2011 Blackwell Publishing Ltd Health Expectations, 14 (Suppl. 1), pp.33–45

36 How engaging does the elicitation technique need to be?, T Crump and H A Llewellyn-Thomas

which is relatively Ôless-intenseÕ, while the other is
relatively Ômore-intenseÕ – and to report, on a nonengaging Leaning Scale, their strength-of-preference scores for the less-intense option, is this
strength-of-preference score inﬂuenced by the
prior use of an engaging Threshold Technique?
We explored this research question using the
following four diﬀerent pairs of relatively ÔlessintenseÕ ⁄ Ômore-intenseÕ options (see Table 1):
1. No drugs vs. drugs that oﬀer longer survival
time but with impaired quality of life.
2. No drugs vs. drugs that oﬀer improved
quality-of-life but with shorter survival time.
3. No respirator vs. respirator that oﬀers a
1-month-longer survival time.
4. No respirator vs. respirator that oﬀers a
1-week-longer survival time.
In the Methods section, below, we provide our
rationale for focusing our research question on
the less-intense therapeutic option in each scenario (see Data Analysis: Preliminary Steps).

Methods
Study participants
A large, nationally-representative telephone
survey of approximately 4000 Medicare beneﬁciaries in the US yielded a sampling frame of 427
potential participants who indicated that they
would be willing to be approached for a more
intensive in-person, follow-up interview.13–16
Potential participants were located in one of four
geographic regions that were deliberately oversampled in the national telephone survey for the
purposes of this in-person interview. Potential
participants were considered eligible if they were
Medicare beneﬁciaries, aged 65 or older on July
1, 2003, English- or Spanish-speaking, not
institutionalized, and able to provide informed
consent to engage in an in-person interview.
Setting
Participants met face-to-face with a trained
community interviewer for a 60-min interview in
their home or other mutually agreeable location.

Table 1 The four end-of-life Decision Scenarios
Decision Scenario #1: No Drugs (Less-Intense Option) vs.
Life-Extending Drugs (More-Intense Option)
Suppose that you had a very serious illness. Imagine that
no one knew exactly how long you would live, but your
doctors said you almost certainly would live less than
1 year.
To deal with that illness, do you think you would
want drugs that might lengthen your life beyond 1 year –
for about 30 additional days – but would make you feel
worse?
Decision Scenario #2: No Drugs (Less-Intense Option)
vs. Quality-of-Life Enhancing Drugs (More-Intense Option)
Suppose that you had a very serious illness. Imagine that
no one knew exactly how long you would live, but your
doctors said you almost certainly would live less than
1 year.
If that illness got to a point that you were feeling
bad all the time, do you think you would want drugs
that would make you feel better, but might shorten your
life by a month?
Decision Scenario #3: No Respirator (Less-Intense Option)
vs. Respirator with 1-Month Life Extension (More-Intense
Option)
Suppose a year ago you were diagnosed with a very
serious illness. Imagine that your doctors had said you
almost certainly would live less than a year.
Suppose the year has passed and the illness has got to the
point that you needed a respirator to stay alive. If it would
lengthen your life for a month, would you want to be put
on a respirator?
Decision Scenario #4: No Respirator (Less-Intense Option)
vs. Respirator with 1-Week Life Extension (More-Intense
Option)
Suppose a year ago you were diagnosed with a very
serious illness. Imagine that your doctors had said you
almost certainly would live less than a year.
Suppose the year has passed and the illness has got to the
point that you needed a respirator to stay alive. If it would
lengthen your life for a week, would you want to be put on a
respirator?

The community interviewer used a standardized,
paper interview guide; each participant also had
a paper copy of the interview guide. The community interviewer guided the participant
through the interview by reading aloud, at the
appropriate points in the interview, the text
outlining the clinical context, choice scenarios,
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stimulus questions, and response choices. The
interview schedule also provided the community
interviewer with standardized responses to frequently-asked questions that might be posed by
the participants (e.g. when presenting the context, the scenarios, or a particular preference
elicitation technique). Participants still could
indicate if they did not understand the context,
scenarios, or questions being asked, or could
refuse to answer any of the questions if they
wished. The study protocol, including all interview and data-collecting materials, was
approved by the Committee for the Protection
of Human Subjects at Dartmouth Medical
School.
Presenting the context and the scenarios
At the appropriate point in the interview, the
participant was asked to consider being diagnosed with a serious illness and having a
prognosis of living no longer than a year. Then
four decision scenarios were presented separately (see Table 1). Each involved a pair-wise
presentation of two health care options: a relatively less-intense and a relatively moreintense option (i.e. leading to lower or higher
demands on health care resources, respectively).
Data collection
For each decision scenario, the same data collection steps were followed. After considering
the scenario and its two relevant therapeutic
options, the participant was asked to select the
option she would favour, if she were actually in
this situation. Then she indicated how strongly
she favoured that option – relative to the
alternative – on a LS. Next, the interviewer
involved the participant in a TT task speciﬁcally
designed for this study. Finally, the participant
was asked to re-consider the scenario and its
two relevant therapeutic options, then again
indicate how strongly she favoured that option
on a new LS. Details about these steps are
provided below, using Decision Scenario 1 as
an example.

The ﬁrst leaning scale
The LS was a horizontally-oriented, 7-point bidirectional ordinal scale.22,23 One therapeutic
option appeared at one end of the scale (e.g. in
Decision Scenario 1, a score of seven means ÔI
strongly favour Ôdrugs that may extend the
length of life by 30 days but might make me feel
worseÕ). The other therapeutic option appeared
at the opposite end (e.g. in Decision Scenario 1,
a score of seven means ‘‘I strongly favour Ôno
drugsÕ’’). There was a labelled neutral point in
the middle.
The participant was asked to indicate how
strongly she would prefer her favoured option
relative to the other, by checking the appropriate
point on this scale. Her response was considered
her raw, non-engaging Ôtime 1Õ LS strength-ofpreference score (i.e. LS1). See Fig. 1 for an
illustrative example.
The threshold technique
After responding to the ﬁrst LS, the participant
worked with the more engaging TT.11 She was
asked to re-consider the same decision scenario,
and again to indicate her favoured option. As
before, for the purposes of illustration, suppose
she was asked to re-consider Decision Scenario 1.
If, in Decision Scenario 1, the participant
initially favoured the Ôno drugsÕ option, then the
30-day length of life extension oﬀered by the
ÔdrugsÕ option was hypothetically increased by
regular increments until the participant indicated that she would switch to favouring the
initially-rejected ÔdrugsÕ option. Thus, the participant who initially weakly favoured the ÔnodrugsÕ option would switch when there is a slight
increase in the length of life extension oﬀered by
the ÔdrugsÕ option, while a participant who initially strongly favoured the same Ôno-drugsÕ
option would not switch until the length of life
extension oﬀered by the ÔdrugsÕ option is considerably increased.
On the other hand, if, in Decision Scenario 1,
the participant initially favoured the ÔdrugsÕ
option, then the 30-day length of life extension
oﬀered by the ÔdrugsÕ option was hypothetically
reduced by regular decrements until the participant indicated that she would switch to favouring
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Figure 1 The Leaning Scale (using
Decision Scenario #1 as an example).

the initially-rejected Ôno drugsÕ option. Thus, the
participant who initially weakly favoured the
ÔdrugsÕ option would switch when there is a slight
decrease in the length of life extension oﬀered by
the ÔdrugsÕ option, while a participant who initially strongly favoured the same ÔdrugsÕ option
would not switch until the length of life extension
oﬀered by the ÔdrugsÕ option is considerably
reduced. See Fig. 2 for an illustrative example.
The second leaning scale
After completing the TT, the participant was
asked to re-consider the same decision scenario,
and again indicate how strongly she would prefer
her favoured option by checking the appropriate
point on a new LS. (The participant was allowed
to review her original response to the LS at Ôtime 1Õ

and was encouraged to consider whether or not
her preferential attitude towards her favoured
option had been aﬀected – either one way or the
other – by the intervening TT. This was deliberately done, in order to oﬀset any assumption the
respondent might make that she was Ôsupposed toÕ
provide the same LS score at Ôtime 2Õ.) Her
response was considered her raw, non-engaging
Ôtime 2Õ LS strength-of-preference score (i.e. LS2).
Data analysis
Preliminary steps
The raw LS scores were converted into a common, uni-directional strength-of preference scale
for analysis. To understand the rationale for the
conversion, it is important to note three points.
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Figure 2 The Threshold Technique
(using Decision Scenario #1 as an
example).

First, the overall purpose of this study was to
determine if there is a method-sequence eﬀect
when participantsÕ strength-of-preference scores
are obtained using a non-engaging LS after
having used an engaging TT. The second point is
that, in order to address this overall purpose in a
consistent manner across all the decision scenarios, it was necessary to convert all participantsÕ raw bi-directional LS scores so that their
converted scores – regardless of their initiallyfavoured option – all lie on the same common,
uni-directional underlying strength-of-preference scale. Finally, these converted LS scores
could have been oriented towards either the
relatively less-intense or the relatively moreintense option; in our conversion, as noted

earlier and as reﬂected in the studyÕs exploratory
research question, the focus was on the lessintense option.
Accordingly: (i) those who initially-favoured
the more-intense option and indicated a raw
score for that option of 7, 6, 5, 4, 3, 2, or 1 on
the bidirectional LS were assigned a recalibrated
score of 1, 2, 3, 4, 5, 6, or 7, respectively;
(ii) those who indicated neutral raw scores of 0
on the bidirectional LS were assigned a recalibrated score of 8; and (iii) those who initiallyfavoured the less-intense option and indicated a
raw score for that option of 1, 2, 3, 4, 5, 6, or 7
on the bidirectional LS were assigned a recalibrated score of 9, 10, 11, 12, 13, 14, or 15,
respectively,
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Thus, in each scenario, all participantsÕ raw
LS scores – regardless of their initially-favoured
option – were converted so as to yield relative
strength-of-preference scores regarding the lessintense option on a new common underlying
scale ranging from a score of 1 (a very low
strength-of-preference score for the less-intense
option) to a score of 15 (a very high strength-ofpreference score for the less-intense option).

variables, while a value of 1.00 indicates perfect
agreement between the variables. It can be
interpreted as the probability of observing
either a concordant (0 £ t £ 1) or discordant
pair ()1 £ t £ 0).24

Analytic steps
Those participants who did not understand the
clinical context, could not indicate an initiallyfavoured option, or refused to answer the
questions, were excluded from the analysis, and
a response rate was calculated for each separate
scenario. For each scenario, descriptive statistics
were used to summarize: the sub-study participantsÕ characteristics; the frequencies at which
the less-intense and more-intense options were
initially-favoured; the responses to the TT; and
the distributions of the converted LS1 and LS2
strength-of-preference scores regarding the lessintense option.
Then, for each scenario, the intra-participant
agreement across the converted LS1 and LS2
strength-of-preference scores for the less-intense
option was assessed using the Kendall tau-b
correlation coeﬃcient (KendallÕs tau). This
nonparametric test can be used to assess the
level of concordance between paired, ordinallevel variables (i.e. the converted LSsÕ scores)
for a speciﬁc observation (i.e. each study participant). KendallÕs tau coeﬃcient values can
range from )1.00 to 1.00. A value of )1.00
indicates perfect disagreement between the

Among the 202 participants, response rates for
the four end-of-life decision scenarios ranged
from 94% (n = 189) to 98% (n = 198). The
participantsÕ average age was 76 years; the
overall sample was 54% female, 92% were
white, 87% were English-speaking, 83% had at
least a high school education, 62% were married, and 75 and 90% considered their physical
and mental health, respectively, to be ÔgoodÕ to
ÔexcellentÕ.

Results
Response rates and participant characteristics

Initially-favoured options
The majority of study participants initially
favoured the less-intense option in three of the
four scenarios; see Table 2.
Strength-of-preference scores on the
unidirectional leaning scale
Recall that, according to the converted unidirectional LS scoring strategy, Ô1Õ is a low
strength-of-preference score and Ô15Õ is a high
strength-of-preference score for the less-intense
option. In all four decision scenarios, the converted LS1 and LS2 scores ranged from 1 and

Table 2 Initially favour less-intense option, initially favour more-intense option, or indifferent between options: frequencies, by
Decision Scenario (N = 202)
Decision Scenario

No drugs

Indifferent

Drugs

Scenario #1: Life-extending drugs vs. no drugs (n = 198)
Scenario #2: Quality-of-life enhancing drugs vs. no drugs (n = 189)

180 (91%)
45 (24%)

6 (3%)
10 (5%)

12 (6%)
134 (71%)

No Respirator

Indifferent

Respirator

167 (86%)
170 (86%)

4 (2%)
6 (3%)

23 (12%)
22 (11%)

Scenario #3: Respirator with 1-month Life extension vs. no respirator (n = 194)
Scenario #4: Respirator with 1-week life extension vs. no respirator (n = 198)
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Table 3 Participants reporting a shift from Time 1 (LS1) to Time 2 (LS2) in unidirectional Leaning Scale scores for the less-intense
option: frequency counts and percentages, by Decision Scenario
Total number
Reporting
any Shift (%)

Decision
Scenario (N)
Scenario
Scenario
Scenario
Scenario

#1
#2
#3
#4

(n
(n
(n
(n

=
=
=
=

198)
189)
194)
198)

47
40
41
22

(23.7%)
(21.1%)
(21.1%)
(11.1%)

Number reporting
higher scores at
Time 2

Number reporting
lower scores

26 (mean increase = 2.42)
20 (mean increase = 2.20)
22 (mean increase = 1.86)
6 (mean increase = 2.50)

21
20
19
16

15, respectively. In three of the four decision
scenarios (Scenarios #1, #3, and #4), the distributions of these converted LS1 and LS2 scores
were dominated by high strength-of-preference
scores for the less-intense option, with modal
scores of 15. However, diﬀerent distributions
were observed for Decision Scenario #2. For
this decision scenario, the distributions of the
converted LS1 and LS2 scores were dominated
by low strength-of-preference scores for the
less-intense option (Ôno drugsÕ), with a modal
score of 1.
The frequency counts of the participants who
reported diﬀerent LS scores at Time 1 and Time
2 are provided in Table 3. For Decision Scenarios #1, #2, #3 and #4, across-time shifts in
the converted LS1 and LS2 scores were observed
for 24, 21, 21 and 11% of the participants,
respectively. Of those participants in whom
shifts were observed, 49, 48, 61 and 41% (for
Decision Scenarios #1–#4, respectively) changed
their strength-of-preference score by only a
single point in either direction.
What happened between LS1 and LS2?
This study primarily focused on whether or
not the TT (as one example of an intervening,
engaging elicitation technique) generated
diﬀerential eﬀects on the converted LS2 scores
(as an example of a non-engaging elicitation
technique). Accordingly, the TT results are not
in themselves of primary interest here. However, in Table 4 we summarize these observations, in order to fully report the results
obtained at all three preference- elicitation
points.

(mean
(mean
(mean
(mean

decrease
decrease
decrease
decrease

Number reporting a
single-point shift
=
=
=
=

2.19)
2.35)
1.84)
1.67)

23 of 47
19 of 40
25 of 41
9 of 22

Answering the research questions
For each of the four exploratory research questions, the intra-participant agreement across the
converted LS1 and LS2 scores was assessed using
KendallÕs tau. Kendall tau-b correlation coeﬃcients of 0.74, 0.84, 0.85 and 0.89 were observed
for each of the four scenarios, respectively; for
all coeﬃcients, P < 0.01.

Discussion
When health care researchers aim to characterize
the distributions of public attitudes towards
diﬀerent elective health care options, they may
wish to use methods that indicate how strongly
diﬀerent members of the public appear to hold
these preferences. Consider, for example, the
perspective of health services researchers who
want to identify unwarranted variations in
preference-sensitive care.13,25 If health services
researchers could clearly identify sub-groups of
community-dwelling individuals who diﬀer
according to the strength of their preferences for
particular health care options, then their
attempts to design, test, and implement interventions to reduce unwarranted variations in
preference-sensitive care could be more eﬃciently targeted, in that they could concentrate
on areas where the gaps between individualsÕ
health care preferences and the care that they
actually receive are widest.26
Before such studies can be conducted, however, several methodological issues have to be
addressed. This study focused on one of those
issues: how engaging does the preference elicitation technique ÔneedÕ to be?
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Table 4 Threshold Technique switch points, by Decision Scenario (N = 202)
Decision
Scenario (n)
Scenario #1
(n = 198)
ÔNo drugs with anticipated
survival of 12 monthsÕ vs.
Ôdrugs with 30-day lifetime
extension, so anticipated
survival is 13 months but
with impaired quality of lifeÕ

Scenario #2 (n = 189)
ÔNo drugs with anticipated
survival of 12 monthsÕ
vs. Ôdrugs with improved
quality of life but with
30-day reduction in lifetime,
so anticipated survival
is 11 monthsÕ

Scenario #3 (n = 194)
ÔNo respirator with anticipated
survival of 12 monthsÕ vs.
Ôrespirator with 30-day lifetime
extension, so anticipated survival
is 13 months but with impaired
quality of lifeÕ

Scenario #4 (n = 198)
ÔNo respirator with anticipated
survival of 12 monthsÕ vs.
Ôrespirator with 7-day lifetime
extension, so anticipated survival
is 12 months + 7 days but with
impaired quality of lifeÕ

TT procedure

Results

If initially favours
Ôno drugsÕ, then increase
lifetime extension with
the ÔdrugsÕ option until
respondent switches
to ÔdrugsÕ
If initially favours
ÔdrugsÕ, then decrease
lifetime extension with
the ÔdrugsÕ option until
respondent switches
to Ôno drugsÕ
If initially favours
Ôno drugsÕ, then decrease
lifetime reduction with
the ÔdrugsÕ option until
respondent switches
to ÔdrugsÕ
If initially favours
ÔdrugsÕ, then increase
lifetime reduction with
the ÔdrugsÕ option until
respondent switches
to Ôno drugsÕ
If initially favours Ôno
respiratorÕ, then increase
lifetime extension with the
ÔrespiratorÕ option until
respondent switches
to ÔrespiratorÕ
If initially favours
ÔrespiratorÕ, then
decrease lifetime
extension with the
ÔrespiratorÕ option until
respondent switches to
Ôno respiratorÕ
If initially favours Ôno
respiratorÕ, then
increase lifetime
extension with the
ÔrespiratorÕ option until
respondent switches to
ÔrespiratorÕ
If initially favours
ÔrespiratorÕ, then
decrease lifetime
extension with the
ÔrespiratorÕ option until
respondent switches to
Ôno respiratorÕ

For 143 (72%),
no amount of lifetime
extension would lead to
accepting these drugs.

For 49 (25%), minimal
required lifetime
extension from these
drugs: mean = 208 days;
median = 180 days.
For 38 (20%),maximal
tolerable lifetime
reduction from
these drugs = 0

For 141 (75%), maximal
tolerable lifetime
reduction from these
drugs: mean = 100 days;
median = 50 days.
For 155 (80%),
no amount of lifetime
extension would lead to
accepting this respirator.

For 32 (16%), minimal
required lifetime
extension from this
respirator: mean = 137 days;
median = 75 days

For 157 (79%),
no amount of lifetime
extension would lead to
accepting this respirator.

For 35 (18%),
minimal required
lifetime extension
from this respirator:
mean = 94 days;
median = 30 days.
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Our exploratory work used four decision scenarios pertaining to an end-of-life context. Each
scenario oﬀered a choice between a relatively
less- or more-intense therapeutic option. After
the participant indicated an initially-favoured
option, she ﬁrst indicated, on a relatively nonengaging bi-directional LS, how strongly she
preferred that initially-favoured option, then she
worked with a relatively engaging TT, and,
ﬁnally, she indicated again, on a new nonengaging bi-directional LS, how strongly she
preferred her initially-favoured option. Subsequently, in order carry out the analysis
required to address our four research questions,
we converted all raw bi-directional LS scores to
uni-directional strength-of-preference scores
oriented towards the less-intense option. In all
four scenarios, we observed a high degree of
concordance between participantsÕ non-engaging
converted LS1 and LS2 strength-of-preferencescores for the less-intense option, in spite of the
intervening engagement with a scenario-speciﬁc
TT.
This observation is noteworthy, given othersÕ
observations about the construction of preferences during the process of preference elicitation,
under controlled experimental conditions. For
example, experiments in psychology have implied
that the nature of the preference elicitation task
can itself inﬂuence a preference report.8 Furthermore, when an individual is faced with a decision
problem that is important, complex, and infrequent – comparable to many health care decision
situations – the manner in which that decision
problem is presented can generate phenomena
such as preference reversals.27,28 It is postulated
that this occurs because the presentation of the
decision problem and the preference elicitation
task themselves act as values clariﬁcation interventions, encouraging participants actively to
work through various attributes of a decision
problem – for example, to engage in active risk
appraisal and evaluation – which, in turn, fosters
the construction and report of previously-unformulated preferences.29,30 However, our observations – albeit in a Ôreal-worldÕ, community-based
interview as opposed to a controlled experiment –
are not consistent with these postulations.

Limitations
The high degrees of concordance that we
observed may actually be a form of Type II error,
generated by four diﬀerent study design issues.
First, perhaps we sampled participants who,
prior to their recruitment into this study, had
already formulated their preferences for the care
they would like to receive at the end of life. If
this were the case, the TT – or any other
engaging elicitation technique – would have
minimal inﬂuence on the subsequent strengthof-preference LS scores, and thus the ability to
detect any method-sequence eﬀects would be
limited. On the other hand, research into the
completion of advanced directives indicates that
as few as 4–25% of speciﬁc patient groups have
provided formal instructions for their care at the
end-of-life, suggesting that the prior formulation
of such preferences actually may not be widely
prevalent amongst the elderly individuals
involved in our study.31 In any case, there is still
a need to use other, non-end-of-life, preferencesensitive decision scenarios in future investigations into possible method-sequence eﬀects.
Second, it is possible that the TT, as it was
designed for this particular application, actually
does not encourage participants actively to
engage in the construction and reporting of
previously-unformulated preferences, as postulated by Fischhoﬀ.29,30 If we had, instead, used a
diﬀerent engaging preference elicitation technique – such as the Balance Technique with the
LS,22 or the Analytic Hierarchy Process10 – we
might have observed a notable method-sequence
eﬀect.
Third, when we used the TT, it is possible that
we worked with a scenario attribute that was not
actually very salient to our participants. Recall
that the attribute used here – overall survival
time – was approached in two diﬀerent ways; in
Scenarios #1, #3 and #4 we worked with lifetime
extension (with a loss in quality-of-life), and in
Scenario #2 we worked with lifetime reduction
(with a gain in quality-of-life). If the attribute of
overall survival time was, in fact, immaterial to
our study participants, then engagement with
this version of the TT would not stimulate shifts
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– either one way or the other – in the LS2 scores.
On the other hand, versions of the TT that
worked with a more salient scenario attribute –
for example, the levels of pain relief oﬀered by
an intervention – might generate shifts in the LS2
scores.32
Finally, it is possible that either the act of
indicating an overall initially-favoured option or
the act of providing a Ôtime 1Õ LS score can, in
itself, create a kind of preferential anchoring
eﬀect. Strictly speaking, an anchoring eﬀect is
generated in a probabilistic context.33 An individual is provided with an objective statement
about the likelihood of a ÔreferenceÕ eventÕs
occurrence, and then is asked to provide her own
subjective estimates of the probability of other,
diﬀerent, events. Her subjective estimates can be
systematically aﬀected by the level of probability
appearing in the original likelihood statement. If
this anchoring phenomenon is also strongly
present in preference-elicitation work, then it is
going to be very diﬃcult to devise study designs
for investigating method-sequencing eﬀects.
There may be ways to oﬀset this kind of artifactual eﬀect. For example, investigators could
lengthen the time interval between the preference
elicitation tasks, and could avoid revealing to
participants the responses they had provided on
the ﬁrst LS. However, the introduction of these
kinds of design controls may actually distort the
preference-elicitation interview either into an
experience in which the respondent assumes that
she ÔmustÕ provide consistent across-technique
responses, or into a format thatÕs not feasible in
a large-scale community survey.

Conclusion
The lack of an apparent method-sequence eﬀect
could imply that future community surveys
aimed at collecting empirical data about the
publicÕs preferential attitudes towards diﬀering
health care options in an end-of-life context may
be able to proceed using the more tractable ÔnonengagingÕ techniques. However, given the
potential limitations to the work reported here,
further methodological research is needed to
more fully investigate the ways in which

respondent characteristics, study designs, and
the elicitation methods themselves interact,
before such an implication could be conclusively
accepted.
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